Stockscreener 앱 받기
7.735
0.96%
-0.075
시장 영업 전:
7.70
-0.035
-0.45%
Genprex Inc 주식(GNPX)의 최신 뉴스
Genprex Inc (GNPX) Institutional Confidence - TradingKey
Genprex Inc (GNPX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Genprex Inc (GNPX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Genprex Inc (GNPX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
GNPX|Genprex Inc|Price:7.810|Chg%:+0.440 - TradingKey
TradingKey - TradingKey
GNPX|Genprex Inc|Price:7.735|Chg%:-0.075 - TradingKey
Genprex Inc Revenue Breakdown – LSE:0A8I - TradingView
AMD Stock Price Today, Analysis, News and Trading Ideas - Stocktwits
Gross margin % of Genprex Inc – MUN:2DE1 - TradingView
CapEx per share of Genprex Inc – MUN:2DE1 - TradingView
Dilution adjustment of Genprex Inc – MUN:2DE1 - TradingView
Total debt of Genprex Inc – MUN:2DE1 - TradingView
Total revenue of Genprex Inc – MUN:2DE1 - TradingView
Genprex (GNPX) Virtual Road Show with CEO Rodney Varner Transcript - GuruFocus
Genprex Inc C-Suite Interview with Noble Capital Markets Transcript - GuruFocus
Genprex (GNPX) Channelchek C-Suite Series, CEO Rodney Varner interview with Noble's Dr. Ahu Demir Transcript - GuruFocus
Genprex Inc Global One Media Interview Transcript - GuruFocus
Genprex Inc at H C Wainwright Global Investment Conference (Virtual) Transcript - GuruFocus
Cash flow from financing activities of Genprex Inc – FWB:2DE1 - TradingView
Net income of Genprex Inc – MUN:2DE1 - TradingView
Genprex Inc (FRA:2DE1) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Genprex Inc (FRA:2DE1) Stock Earnings Transcripts - GuruFocus
Net income of Genprex Inc – FWB:2DE1 - TradingView
Genprex Inc (STU:2DE1) Stock Price & 30 Year Financial Data - GuruFocus
Genprex Inc (STU:2DE1) Stock Earnings Transcripts - GuruFocus
Genprex Inc (STU:2DE1) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
Genprex (GNPX) Q1 2026 Earnings: Pre-Revenue Biotech Reports Net Loss of -$0.64 Per ShareEarnings Call Q&A - dars.gov.et
Genprex Announces Reverse Stock Split Amid Nasdaq Compliance Push - TipRanks
Genprex Inc. (GNPX) Edges Higher Amid Tight Trading RangeAggressive Growth Picks - dars.gov.et
Stock Splits Calendar for: - Yahoo! Finance Canada
Genprex Inc. (GNPX) Slides 5% as Biotech Stock Tests Key SupportFibonacci Arc - dars.gov.et
Genprex Shows Resilience: GNPX Climbs 7.8% on Renewed Biotech InterestAnchored VWAP - DonanımHaber
GNPX Q1 2026 Earnings: Clinical-Stage Biotech Reports Net Loss as Pipeline Development ContinuesROIC Trend Report - DonanımHaber
Genprex Inc. (GNPX) Surges Over 5% as Key Support Holds FirmETF Liquidity - dars.gov.et
Genprex (GNPX) Hovers Near Support After Modest Gain, Consolidation Pattern EmergesGamma Squeeze - dars.gov.et
GNPX Q1 2026 Earnings: Clinical-Stage Biotech Reports Net Loss Per Share of $0.64 Amid Ongoing DevelopmentMargin Guidance - dars.gov.et
GNPX Q1 2026 Earnings: Pre-Revenue Biotech Reports Net Loss Per Share of $0.64 as Stock Rises 2.06%Quarterly Financial Update - dars.gov.et
GNPX Q1 2026 Earnings: Net Loss of $0.64 Per Share as Stock Climbs 5.03%Forward Guidance Trends - dars.gov.et
Genprex Inc. (GNPX) Stages Modest Recovery, Testing Key Resistance LevelLeveraged ETF Flow - dars.gov.et
Genprex | 8-K: Current report - Moomoo
$Genprex (GNPX.US)$ - Moomoo
GNPX Should I Buy - Intellectia AI
Enterprise value to EBIT forward of Genprex, Inc. – NASDAQ:GNPX - TradingView
Price to sales forward of Genprex, Inc. – NASDAQ:GNPX - TradingView
Price to earnings forward of Genprex, Inc. – NASDAQ:GNPX - TradingView
Price to book forward of Genprex, Inc. – NASDAQ:GNPX - TradingView
Enterprise value to revenue forward of Genprex, Inc. – NASDAQ:GNPX - TradingView
Genprex Inc Actuals & Estimates (NASDAQ:GNPX) - TradingView
GNPX Q1 2026 Earnings: Pre-Revenue Biotech Reports Net Loss of $0.64 per ShareGuidance Upgrade Report - dars.gov.et
Genprex’s Reqorsa combo secures Canadian patent for lung cancer - Yahoo Finance
GNPX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Genprex receives Canadian patent allowance for cancer therapy combination - Investing.com UK
Genprex, Inc. Files SEC Form 8-K: Company Details, Nasdaq Listing, and Key Corporate Information (June 22, 2026) - Minichart
Genprex (GNPX) Secures New Patent for Reqorsa Gene Therapy - GuruFocus
Form 8K Genprex Inc For: 22 June - Investing.com UK
Genprex Secures Canadian Patent for Reqorsa Lung Cancer Therapy - TipRanks
Form 8K Genprex Inc For: 22 June By Investing.com - Investing.com South Africa
Genprex receives Canadian patent allowance for cancer therapy combination By Investing.com - Investing.com South Africa
1.97%
0.83%
자본화:
|
볼륨(24시간):